Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis.

Okuda Y, Yamada T, Matsuura M, Takasugi K, Goto M.

Amyloid. 2011 Sep;18(3):108-11. doi: 10.3109/13506129.2011.582198. Epub 2011 Jun 1.

PMID:
21627560
2.

A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis.

Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, Inada S, Kamatani N.

Arthritis Rheum. 2001 Jun;44(6):1266-72.

3.

Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.

Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, Shono M.

Rheumatology (Oxford). 2006 Jan;45(1):43-9. Epub 2005 Oct 11.

PMID:
16219644
4.

Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis.

Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, Nishinarita M, Uchida S, Nakajima A, Kim SY, Chen CL, Kamatani N.

Hum Genet. 1999 Oct;105(4):360-6.

PMID:
10543406
5.
6.

Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.

Nakamura T, Higashi S, Tomoda K, Tsukano M, Shono M.

Rheumatology (Oxford). 2012 Nov;51(11):2064-9. doi: 10.1093/rheumatology/kes190. Epub 2012 Aug 9.

PMID:
22879465
7.

An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians.

Yamada T, Okuda Y, Takasugi K, Wang L, Marks D, Benson MD, Kluve-Beckerman B.

Amyloid. 2003 Mar;10(1):7-11.

PMID:
12762135
8.

Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.

Nakamura T.

Mod Rheumatol. 2008;18(2):109-18. doi: 10.1007/s10165-008-0035-2. Epub 2008 Mar 4. Review.

PMID:
18369528
9.

SAA1 alleles as risk factors in reactive systemic AA amyloidosis.

Booth DR, Booth SE, Gillmore JD, Hawkins PN, Pepys MB.

Amyloid. 1998 Dec;5(4):262-5.

PMID:
10036584
10.

HLA-DRB1*04 alleles in Japanese rheumatoid arthritis patients with AA amyloidosis.

Migita K, Nakamura T, Maeda Y, Miyashita T, Origuchi T, Yatsuhashi H, Nakamura M, Ishibashi H, Eguchi K.

J Rheumatol. 2006 Nov;33(11):2120-3.

PMID:
17086601
11.

A novel allelic variant of serum amyloid A, SAA1 gamma: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis.

Baba S, Masago SA, Takahashi T, Kasama T, Sugimura H, Tsugane S, Tsutsui Y, Shirasawa H.

Hum Mol Genet. 1995 Jun;4(6):1083-7.

PMID:
7655463
12.

Relative transcriptional activities of SAA1 promoters polymorphic at position -13(T/C): potential association between increased transcription and amyloidosis.

Moriguchi M, Kaneko H, Terai C, Koseki Y, Kajiyama H, Inada S, Kitamura Y, Kamatani N.

Amyloid. 2005 Mar;12(1):26-32.

PMID:
16076608
13.
14.

SAA1 alpha/alpha alleles in amyloidosis.

Kelkitli E, Bilgici B, Tokgöz B, Dilek M, Bedir A, Akpolat I, Utas C, Akpolat T.

J Nephrol. 2006 Mar-Apr;19(2):189-91.

PMID:
16736418
15.

Genotypes at SAA1 locus correlate with the clinical severity of AA-amyloidosis.

Moriguchi M, Terai C, Koseki Y, Kaneko H, Uesato M, Nishikawa T, Kamatani N.

Amyloid. 2001 Jun;8(2):115-20. No abstract available.

PMID:
11409033
17.

[Secondary amyloidosis in patients with rheumatoid arthritis(RA)].

Inada S.

Nihon Rinsho. 2002 Dec;60(12):2417-22. Review. Japanese.

PMID:
12510371
18.

[Serum amyloid A (SAA) 1, SAA 2 and apolipoprotein E isotype frequencies in rheumatoid arthritis patients with AA amyloidosis].

Okuda Y, Yamada T, Takasugi K, Takeda M, Nanba S, Onishi M, Miyamoto T, Inoue Y.

Ryumachi. 1999 Feb;39(1):3-10. Japanese.

PMID:
10332210
19.

Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.

Nakamura T, Yamamura Y, Tomoda K, Tsukano M, Shono M, Baba S.

Clin Rheumatol. 2003 Dec;22(6):371-5. Epub 2003 Nov 7.

PMID:
14677008
20.

Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis.

van der Hilst JC, Yamada T, Op den Camp HJ, van der Meer JW, Drenth JP, Simon A.

Rheumatology (Oxford). 2008 Nov;47(11):1651-4. doi: 10.1093/rheumatology/ken371. Epub 2008 Sep 24.

PMID:
18815155

Supplemental Content

Support Center